abstract |
The present invention relates to a variant and fusion of fibroblast growth factor 19 (FGF19), a variant and fusion of fibroblast growth factor 21 (FGF21), fibroblasts having one or more activities such as glucose lowering activity Fusion factor of growth factor 19 (FGF19) and / or fibroblast growth factor 21 (FGF21), and protein sequence and peptide sequence of fibroblast growth factor 19 (FGF19) and / or fibroblast growth factor 21 (FGF21) (And peptidomimetics) variants or fusions, and methods of treatment and use in the treatment of hyperglycemia and other disorders. [Selection] Figure 3A |